| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
1436 |
| issn |
0012-6667
1179-1950 |
| issueIdentifier |
10 |
| pageRange |
1423-1436 |
| publicationName |
Drugs |
| startingPage |
1423 |
| bibliographicCitation |
Frampton JE. Vandetanib: in medullary thyroid cancer. Drugs. 2012 Jul 09;72(10):1423–36. doi: 10.2165/11209300-000000000-00000. PMID: 22715896. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d85c0dca40a8809052e235ceba1ecf4 |
| date |
2012-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.2165/11209300-000000000-00000
https://pubmed.ncbi.nlm.nih.gov/22715896 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453
https://portal.issn.org/resource/ISSN/0012-6667
https://portal.issn.org/resource/ISSN/1179-1950 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Vandetanib: in medullary thyroid cancer |
| discusses |
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0421253
http://id.nlm.nih.gov/mesh/M0017888
http://id.nlm.nih.gov/mesh/C536914
http://id.nlm.nih.gov/mesh/M0016885
http://id.nlm.nih.gov/mesh/M0018336 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_44254e68817007e1a192f8a1c333eaf8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID1544
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8355
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2cb9df9898e55fd0ad829dc202ddbd1c |